News

Prelude Therapeutics Gears Up for Barclays Global Healthcare Event

Prelude Therapeutics Gears Up for Barclays Global Healthcare Event

Prelude Therapeutics Gears Up for Barclays Global Healthcare Event

WILMINGTON, Del. — Prelude Therapeutics Incorporated (NASDAQ: PRLD), a clinical-stage precision oncology company, has announced its participation in the upcoming Barclays 27th Annual Global Healthcare Conference. The event will take place in Miami on March 11, providing a platform for key discussions surrounding innovations in cancer treatment.

During this significant event, the CEO of Prelude, Kris Vaddi, Ph.D., along with Jane Huang, M.D., President and Chief Medical Officer, and CFO Bryant Lim, will engage in a fireside chat at 12:30 p.m. ET. This conversation will focus on the latest advancements and strategic initiatives at Prelude, highlighting the company’s commitment to enhancing patient outcomes in oncology.

For those interested in following the discussion, a live webcast of the chat will be accessible via the Company’s official website. Furthermore, the recording will be available for viewing afterward, ensuring that stakeholders can engage with the content for up to 90 days post-event.

Innovation in Oncology

Prelude Therapeutics is at the forefront of precision oncology, dedicated to creating innovative medicines aimed at addressing critical needs in cancer care. The company’s pipeline features several groundbreaking drug candidates, including first-in-class SMARCA2 degraders, which are designed to be highly selective in their action. Additionally, they are developing a potentially best-in-class CDK9 inhibitor.

Moreover, Prelude is leveraging its expertise in targeted protein degradation to develop next-generation degrader antibody conjugates, often referred to as Precision ADCs. These developments not only showcase Prelude’s innovative capabilities but also highlight its mission to make precision medicine accessible to all cancer patients in need.

About the Company

Prelude Therapeutics is grounded in the belief that every cancer patient deserves access to groundbreaking treatments. The company's efforts are focused on developing medicines for conditions that lack adequate treatment options. With a strong emphasis on collaboration, Prelude seeks to partner with other entities to accelerate the development of its innovative therapies and reach a broader patient population.

The company's commitment to research and development showcases not only its dedication but also its strategic vision for the future of oncology. By prioritizing areas of high unmet need, Prelude aims to transform the landscape of cancer treatment and improve the quality of life for patients worldwide.

Investor Relations

For those looking to connect, the investor contact for Prelude Therapeutics is Robert Doody, the Senior Vice President of Investor Relations. He is available at 484.639.7235 and can also be reached via email for inquiries regarding the company and its developments.

Community Engagement

As part of its commitment to fostering a knowledgeable community around its innovations, Prelude actively engages in informational exchanges at various conferences and presentations. This participation not only aids in disseminating vital information but also strengthens relationships within the healthcare ecosystem.

Frequently Asked Questions

What event is Prelude Therapeutics participating in?

Prelude Therapeutics is participating in the Barclays 27th Annual Global Healthcare Conference in Miami.

Who will represent Prelude at the conference?

The CEO, CTO, and CFO of Prelude will participate in a fireside chat at the event.

How can I access the webcast of the chat?

The live webcast will be available on the Company’s website during the chat and archived for future viewing.

What are some key products in Prelude's pipeline?

Prelude’s pipeline includes innovative drug candidates, such as SMARCA2 degraders and a CDK9 inhibitor.

Who can I contact for investor inquiries about Prelude?

Robert Doody is the contact for investor relations, reachable at 484.639.7235 or via email.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lektra Unveils EdgeStart: Green Earnings from AI

Updated Category News Views 54

AI and Solar Power: A New Revenue Stream Lektra's fresh off the blocks with EdgeStart, an AI server pushing building owners to make a buck off their idle solar power. These self-contained, 8-GPU NVIDIA cabinets don't just sit pretty; they’re money-makers, potentially turning an overlooked asset into a goldmine. If your building's solar panels are just loafing about...

Continue Reading
Kyungtz'e Eosan Sooryukje: Honoring Spirits and History

Updated Category News Views 24

An Enchanting Ritual Comes to NYC Some things transcend the humdrum of everyday life, and right now, New York's set to witness exactly that. It's not every day you get treated to Korea's deep-rooted Buddhist traditions, but come November 13 and 14, that's precisely what's in store. The Korean Cultural Center New York (KCCNY) is bringing Kyungtz'e Eosan Sooryukje to the...

Continue Reading
Set Hach: A Leader Transforming Agrifood Systems

Updated Category News Views 0

From Humble Beginnings to Global Recognition When a name like Set Hach doesn't just echo within local circles but reaches the global stage, you know something transformative is brewing. Here we have a woman celebrated as one of the 100 Women Heroes in Agrifood Systems by the UN Food and Agriculture Organization (FAO). Recognition like this speaks volumes, especially...

Continue Reading
Compal and ARC Cloud Forge AI Partnership

Updated Category News Views 81

AI Infrastructure: A New Era of Collaboration Well, here's one that's got my old trader veins throbbing with excitement. Compal Electronics and ARC Cloud are shaking hands in a deal that could sketch out a bold new chapter in AI infrastructure. This ain't your run-of-the-mill tech announcement; it's a strategic dance aimed at supercharging the very backbone of large-scale...

Continue Reading
Piramal Pharma FY27 Q2 Results: Robust Growth & Optimism

Updated Category News Views 12

A Solid Performance from Piramal Pharma The numbers are in, and it's looking pretty good for Piramal Pharma Limited this time around. Their second quarter of fiscal year 2027 has seen some fireworks, and I'm not talking about some half-baked confetti deal. We're talking genuine growth and solid metrics here. Revenue and Profit Surge The headline? Revenue jumped a whopping...

Continue Reading
Right Heart Failure Gains Recognition as Its Own Syndrome

Updated Category News Views 24

Changing the Narrative on Right Heart Failure How often do we see right heart failure (RHF) brushed aside like some understudy in the grand play of cardiovascular disease? Far too often, according to the Heart Failure Society of America (HFSA). They're here to shift that narrative, demanding RHF be recognized for what it truly is: a distinct clinical syndrome. Forget...

Continue Reading
Ultrasound Innovations: 2D, 3D, and 4D Explained

Updated Category News Views 24

Diving into the World of Ultrasound Imaging When you're in the trenches of expecting a new family member, the last thing you want is to get bogged down in technical jargon that doesn't make a lick of sense. Enter prenatal ultrasound imaging: 2D, 3D, and 4D. Each of these has a specific role in piecing together the puzzle of fetal development. Now, Erika Lambright, a...

Continue Reading
Steel Vet Shift: John Pritchett Takes Helm at Trojan

Updated Category News Views 6

Trojan Steel's Bold Move with John Pritchett at the Helm Trojan Steel is changing the game by appointing John C. Pritchett as its new President. This isn't just another shuffle of suits in the boardroom—it's a statement. Pritchett isn't some steel industry old-timer; instead, he's a business leader with a knack for scaling operations. With a resume that includes...

Continue Reading
BNY's Conference Spotlight: Strategic Moves Ahead?

Updated Category News Views 38

BNY's CFO to Unpack Strategies at BMO Financials Conference They say you can tell a lot about a company by the folks steering the ship. And let me tell you, folks, Dermot McDonogh from BNY is setting sail over to Boca Raton to spill some beans. November 9 marks the date when BNY’s Chief Financial Officer will stand behind the mic at the BMO Financials Conference at 8:45...

Continue Reading
Americans' Faith in Democracy Hits New Lows

Updated Category News Views 82

Polarization Beyond Politics: A National Reckoning When you catch wind of a report like this one, it's enough to make you feel like the fabric of democracy is unraveling right before our eyes. We're staring at a national identity crisis, folks, and it's got nothing to do with whether you're waving a red or blue flag. This ain't about party lines; it's about a bigger,...

Continue Reading

Top 5 Most Recently Viewed Articles

FFB Bancorp Posts $8.56 Million Profit in Latest Quarter

Updated Category News Views 138

FFB Bancorp Reports Strong Financial Growth FFB Bancorp, the parent company of FFB Bank, recently announced a net income of $8.56 million, equating to $2.69 per diluted share for the third quarter of 2024. This represents a 6% increase from the prior quarter's earnings of $8.08 million or $2.54 per diluted share. Notably, the Bank's net income was a robust $8.87 million...

Continue Reading
Allegion's Participation in the Barclays Industrial Conference

Updated Category News Views 219

Allegion to Attend 2025 Barclays Industrial Select Conference Allegion plc (NYSE: ALLE) is set to showcase its forward-thinking strategy at the prestigious Barclays Industrial Select Conference. President and CEO John H. Stone will take center stage, sharing insights into the company’s future direction and innovative approach to security solutions. This important event...

Continue Reading
EO Charging Wins Recognition for Innovative Fleet Solutions

Updated Category News Views 195

EO Charging Honored with Frost & Sullivan Award EO Charging has recently received the prestigious Frost & Sullivan Product Leadership Award for its significant contributions to energy efficiency and reliability in fleet charging and management. This recognition highlights EO's innovative solutions that transform the landscape of electric vehicle (EV) charging for...

Continue Reading
Exploring Veeva Systems: A Decade of Growth and Performance

Updated Category News Views 1052

Veeva Systems: A Decade of Triumph Veeva Systems (NYSE: VEEV) has displayed remarkable growth over the past ten years, consistently outperforming the market averages by an impressive 15.47% annually. Investors have generally enjoyed a substantial average annual return of 28.63%, a testament to the company’s robust business model and strategic foresight. Market...

Continue Reading
Panorama Pathways: Innovating Student Graduation Tracking

Updated Category News Views 178

Introducing Panorama Pathways for Student Success In an exciting step forward for educational technology, Panorama Education has rolled out Panorama Pathways, a groundbreaking tool aimed at increasing on-time graduation rates among students. This innovative product emerged from the company's acquisition of Mesa Cloud in 2023, showcasing their dedication to empowering...

Continue Reading